What’s next for cancer vaccines-Reference-Cited by-同舟云学术

What’s next for cancer vaccines

Published:2022-11-09 Issue:670 Volume:14 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Adamik Juraj¹,Butterfield Lisa H.¹^ORCID

Affiliation:

1. Parker Institute for Cancer Immunotherapy, University of California, San Francisco, Suite D3500, 1 Letterman Drive, San Francisco, CA 94129, USA.

Abstract

Cancer vaccines have been shown clinically to drive tumor-reactive cell activation, proliferation, and effector function. Unfortunately, tumor eradication by treatment with cancer vaccines has been unsuccessful in many patients. Critical steps are under way to improve vaccine efficacy and combine them with immunotherapy and standard-of-care treatments.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference44 articles.

1. Oncology Meets Immunology: The Cancer-Immunity Cycle

2. Adenovirus MART-1–engineered Autologous Dendritic Cell Vaccine for Metastatic Melanoma

3. Determinant spreading associated with clinical response in dendritic cell-based immunotherapy for malignant melanoma;Butterfield L. H.;Clin. Cancer Res.,2003

4. A novel allogeneic off-the-shelf dendritic cell vaccine for post-remission treatment of elderly patients with acute myeloid leukemia

5. Identifying and Targeting Human Tumor Antigens for T Cell-Based Immunotherapy of Solid Tumors

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In situ tumor cell engineering reverses immune escape to enhance immunotherapy effect;Acta Pharmaceutica Sinica B;2024-09

2. Progress on immuno-microenvironment and immune-related therapies in patients with pseudomyxoma peritonei;Cancer Biology & Medicine;2024-07-18

3. The role of circular RNAs in regulating resistance to cancer immunotherapy: mechanisms and implications;Cell Death & Disease;2024-05-02

4. The future of cancer vaccines against colorectal cancer;Expert Opinion on Biological Therapy;2024-04-02

5. Immune Specific and Tumor-Dependent mRNA Vaccines for Cancer Immunotherapy: Reprogramming Clinical Translation into Tumor Editing Therapy;Pharmaceutics;2024-03-25